Montreal, May 8, 2014 – Sanofi Canada is proud to announce that Allerject™, its epinephrine auto-injector, is now an official partner of the Montreal Impact.
Allerject™ is teaming up with the professional soccer club and its home, Stade Saputo, to promote public awareness of severe allergies and the emergency treatment of anaphylaxis.
The Montreal Impact and its Academy teams are already big fans of Allerject™, stocking the auto-injector in their emergency medical kits. Stade Saputo also keeps Allerject™ at its first-aid stations.
The new partnership agreement will see the creation of an Allerject™ Zone at the stadium where fans will learn about what anaphylaxis is, and about the latest 'talking' epinephrine auto-injector, Allerject™.
"This a tremendous opportunity for Sanofi Canada not only to support the great game of soccer and a favourite sports team in our community, but also to work with the Impact organization and its many fans in building public awareness of anaphylaxis and how to be prepared in the event of an emergency," said Sanofi Canada President and CEO, Jon Fairest.
A media event will be held soon to officially announce the partnership.
For more information about Allerject™, visit www.allerject.ca or follow us on Twitter (@Allerject). For more information about the Montreal Impact, visit impactmontreal.com, follow @impactmontreal on Twitter and impactmontreal on Facebook.
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi entities in Canada include Sanofi Canada (pharmaceuticals), Sanofi Pasteur (vaccines), Sanofi Consumer Health (cosmeceuticals, over-the-counter products and specialty care), Genzyme (rare diseases) and Merial (animal health). Together they employ close to 1,700 people across the country. In 2013 Sanofi companies invested $125,1 million in R&D in Canada, creating jobs, business and opportunity throughout the country.
